What are the first-line treatment options for giardiasis in children?

First-line treatment options for giardiasis in children primarily include 5-nitroimidazole compounds such as metronidazole, which is widely recommended in UK clinical practice due to its efficacy and safety profile ¹. Alternative nitroimidazoles like tinidazole may also be used, often as a single-dose regimen, which can improve adherence in paediatric patients ¹. Recent systematic reviews and meta-analyses of Cuban children with giardiasis support the high efficacy of these 5-nitroimidazole drugs, confirming their role as first-line agents (Escobedo et al., 2019). The literature further suggests that these medications are effective in achieving parasitological cure and symptom resolution, reinforcing their use in children ¹ (Escobedo et al., 2019). While UK guidelines focus on metronidazole as the standard, the evidence from recent studies indicates that other nitroimidazoles may be equally effective and could be considered based on clinical circumstances (Escobedo et al., 2019).